| Título : |
In vitro evaluation of lomefloxacin activity in Colombia |
| Tipo de documento : |
documento electrónico |
| Autores : |
Hugo Trujillo Soto, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., ; C. Gómez, |
| Fecha de publicación : |
1989 |
| Títulos uniformes : |
Diagnostic Microbiology and Infectious Disease
|
| Idioma : |
Inglés (eng) |
| Resumen : |
As part of the worldwide in vitro program to determine the antimicrobial activity of lomefloxacin, our study tested susceptibility of bacterial isolates from hospitals in Medellin, Colombia. A total of 504 bacterial isolates were obtained from patients at three different centers. For Enterobacteriaceae, 0.5 μg/ml inhibited 100% of the indole-positive Proteus and Salmonella spp.; 1 μg/ml inhibited 100% of Shigella and Citrobacter, 2 μg/ml inhibited 100% of Enterobacter spp., E. coli, Proteus mirabilis, and Serratia marcescens isolates tested. The MIC90 for Klebsiella spp. and Pseudomonas spp. was 4 μg/ml. The MIC90 was 4 μg/ml for S. aureus and 2 μg/ml for S. epidemidis and S. saprophyticus. The MIC90 of Streptococcus spp. were ⩽4 μg/ml for all isolates tested. Considering that 97.8% were susceptible to concentrations of ⩽4 μg/ml of lomefloxacin, this new quinolone offers potential in the therapy of a variety of systemic infections, especially in patients with multiply resistant pathogens. |
| Mención de responsabilidad : |
H Trujillo, G I Mejia, L Castrillon, C Gomez |
| Referencia : |
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):51S-52S |
| DOI (Digital Object Identifier) : |
10.1016/0732-8893(89)90066-7 |
| PMID : |
2791498 |
| En línea : |
https://linkinghub.elsevier.com/retrieve/pii/0732889389900667 |
| Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis |
In vitro evaluation of lomefloxacin activity in Colombia [documento electrónico] / Hugo Trujillo Soto, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., ; C. Gómez, . - 1989. Obra : Diagnostic Microbiology and Infectious DiseaseIdioma : Inglés ( eng)
| Resumen : |
As part of the worldwide in vitro program to determine the antimicrobial activity of lomefloxacin, our study tested susceptibility of bacterial isolates from hospitals in Medellin, Colombia. A total of 504 bacterial isolates were obtained from patients at three different centers. For Enterobacteriaceae, 0.5 μg/ml inhibited 100% of the indole-positive Proteus and Salmonella spp.; 1 μg/ml inhibited 100% of Shigella and Citrobacter, 2 μg/ml inhibited 100% of Enterobacter spp., E. coli, Proteus mirabilis, and Serratia marcescens isolates tested. The MIC90 for Klebsiella spp. and Pseudomonas spp. was 4 μg/ml. The MIC90 was 4 μg/ml for S. aureus and 2 μg/ml for S. epidemidis and S. saprophyticus. The MIC90 of Streptococcus spp. were ⩽4 μg/ml for all isolates tested. Considering that 97.8% were susceptible to concentrations of ⩽4 μg/ml of lomefloxacin, this new quinolone offers potential in the therapy of a variety of systemic infections, especially in patients with multiply resistant pathogens. |
| Mención de responsabilidad : |
H Trujillo, G I Mejia, L Castrillon, C Gomez |
| Referencia : |
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):51S-52S |
| DOI (Digital Object Identifier) : |
10.1016/0732-8893(89)90066-7 |
| PMID : |
2791498 |
| En línea : |
https://linkinghub.elsevier.com/retrieve/pii/0732889389900667 |
| Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis |
|  |
Inicio
Clasificado(s) por (Año de edición descendente) Refinar búsquedaIn vitro evaluation of lomefloxacin activity in Colombia / Hugo Trujillo Soto ; Gloria Isabel Mejía de Rodríguez ; Lucero Castrillón de P. ; C. Gómez
